NIFTY 50

Market expert SP Tulsian is bullish on these three pharma stocks

Updated : February 20, 2020 03:52 PM IST

In his latest analysis and commentary, stock market expert SP Tulsian of sptulsian.com gave his top stock picks in an interview with CNBC-TV18.

SP Tulsian is a well-known equity analyst. A fundamental analyst with more than three decades of experience, Tulsian has an acute sense of logic and is respected for his frank and forthright views.

Speaking about the pharmaceutical sector, he said, “We have been selective on three stocks – Aurobindo Pharma, Divis Lab and Biocon and we continue to have positive bias even at the current level and going forward from the medium-term point of view.”

Talking about banks, he said, “I am confident that Vodafone will pay close to Rs 15,000-20,000 crore which will be seen as a good kicker for corporate lenders like IndusInd Bank, SBI, ICICI Bank, Axis Bank and HDFC Bank.”

“SBI Cards IPO will make the SBI shares go up in the next couple of weeks because the IPO documents will get filed with Registrars of Companies soon. So overall I am keeping an extremely positive view on Bank Nifty in spite of 31,100-target given by me which met today,” he added.

When asked about Max Financial Services, Tulsian said, “Max Financial is a high beta stock and swiftly corrects, either way, 10 percent plus-minus. So it's risky. But for those who want to play safe, there are other better avenues available even in insurance space. So I will advise going for profit-booking in Max Financial at the current level.”

cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV